SV Life Sciences Fund IV (GP), L.P.
10% owner at KALV; 10% owner at IVERIC bio, Inc.; 10% owner at NeurogesX Inc
- Sold, on record
- $46.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 28, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- KALVKalVista Pharmaceuticals, Inc.10% owner
- IVERIC bio, Inc.10% owner
- NeurogesX Inc10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- IVERIC bio, Inc.980,127 shares
- NeurogesX Inc300,000 shares
- KALV126,811 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale NeurogesX IncUnusualMay 3, 2010 2010
Sold 300,000 shares at $10.25 ($3.1M)
SV Life Sciences Fund IV (GP), L.P., 10% owner
Sold 83% of holdings ($3.7M position)61,324 shares leftFirst sale on recordFiling
- 2 Form 4 sale IVERIC bio, Inc.Plan not statedMay 28, 2014 +1486 days
Sold 980,127 shares at $40.19 ($39.4M)
SV Life Sciences Fund IV (GP), L.P., 10% owner
Sold 17.4% of holdings ($226M position)4.6M shares leftFirst sale on recordFiling
- 3 Form 4 sale KALVPlan not statedDec 19, 2018 +1666 days
Sold 2,136 shares at $20.02 ($43k)
SV Life Sciences Fund IV (GP), L.P., 10% owner
Sold 2.9% of holdings ($1.5M position)71,152 shares leftFirst sale on recordFiling
- 4 Form 4 sale KALVUnusualMar 28, 2019 +99 days
Sold 124,675 shares at $28.84 ($3.6M)
SV Life Sciences Fund IV (GP), L.P., 10% owner
Sold 70.8% of holdings ($5.1M position)51,531 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2019 | Mar 28, 2019 | KALV | 10% owner | Form 4 sale | 124,675 | $3.6M | 70.8% | Unusual | SEC |
| Dec 19, 2018 | Dec 21, 2018 | KALV | 10% owner | Form 4 sale | 2,136 | $43k | 2.9% | Plan not stated | SEC |
| May 28, 2014 | May 29, 2014 | IVERIC bio, Inc. | 10% owner | Form 4 sale | 980,127 | $39.4M | 17.4% | Plan not stated | SEC |
| May 3, 2010 | May 5, 2010 | NeurogesX Inc | 10% owner | Form 4 sale | 300,000 | $3.1M | 83.0% | Unusual | SEC |